Lenima Field Diagnostics is Biotechnology in United States that focus on molecular diagnostic test business. Founded in 2013. They cover business area such as developer, molecular diagnostic test, low-cost treatment, infectious disease, piezoelectric plate sensor, detection, cancer marker, enable simplification, genetic testing process, low cost, rapid testing, multiple nucleic acid.
2013
( 11 years old in 2024 )
Molecular Diagnostic Test
-
3624 Market Street
Suite 5E
Philadelphia, PA 19104
United States
Private
developermolecular diagnostic testlow-cost treatmentinfectious diseasepiezoelectric plate sensordetectioncancer markerenable simplificationgenetic testing processlow costrapid testingmultiple nucleic acid
* We use standard office opening hours in near Lenima Field Diagnostics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Lenima Field Diagnostics is Biotechnology business from United States that founded in 2013 (11 years old in 2024), Lenima Field Diagnostics business is focusing on Molecular Diagnostic Test.
Lenima Field Diagnostics headquarter office and corporate office address is located in 3624 Market Street Suite 5E Philadelphia, PA 19104 United States.
Lenima Field Diagnostics was founded in United States.
In 2024, Lenima Field Diagnostics is currently focus on molecular diagnostic test sector.
Above is snippet of Google Trends for "molecular diagnostic test" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Lenima Field Diagnostics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
